Title of Collaborative Activity: |
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group |
Description of Collaborative Activity: |
A group of Therapeutics for Rare and Neglected Diseases (TRND) Program staff and US Food and Drug Administration (FDA) staff from the Center for Drug Evaluation and Research (CDER) meet on a monthly basis to discuss projects for the TRND program. The purpose of this working group is to discuss regulatory science toward the eventual goal of an Investigational New Drug Application. Results of experiments are discussed, and TRND staff and FDA/CDER staff exchange ideas that are taken into consideration when developing TRND project plans. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2009 |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS |
HHS Agency Collaborators on this Activity: |
FDA |
